Literature DB >> 29151252

Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Nicola Pirozzi1,2, Antonella Stoppacciaro1,3, Paolo Menè4,5,6.   

Abstract

Recently, a number of reports have described dominant C3 deposits in renal biopsies of patients with infection-related glomerulonephritis (GN). While acute post-infectious GN and membranoproliferative GN are commonly characterized by immune deposits containing C3 and/or C4, the absence of immunoglobulin (Ig) and/or immune complexes at light or electron microscopy is a rather unusual observation. Dominant C3 deposition is believed to result from the alternative pathway of complement activation via the C3bBb "tickover" convertase. The actual occurrence of C3 glomerulopathy could be underestimated, since infection-related GN often quickly subsides without the need for a renal biopsy. A more thorough understanding of the pathways that lead to complement assembly and deposition within the kidney is needed to support a new classification of complement-related lesions, including entities such as dense deposit disease, (atypical) hemolytic-uremic syndrome, dominant C1q, CFHR5, C4d, and C3 glomerulopathies. We will briefly review recent work in this area, focusing on GN with selective complement C3 deposits.

Entities:  

Keywords:  C3; Complement; Glomerulonephritis; Immune deposits; Renal biopsy

Mesh:

Substances:

Year:  2017        PMID: 29151252     DOI: 10.1007/s40620-017-0458-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  47 in total

1.  Expanding the Domain of Postinfectious Glomerulonephritis.

Authors:  William G Couser; Richard J Johnson
Journal:  Am J Kidney Dis       Date:  2015-10       Impact factor: 8.860

2.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 3.  Basic and translational concepts of immune-mediated glomerular diseases.

Authors:  William G Couser
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

4.  C3 glomerulopathy: clinicopathologic features and predictors of outcome.

Authors:  Nicholas R Medjeral-Thomas; Michelle M O'Shaughnessy; John A O'Regan; Carol Traynor; Michael Flanagan; Limy Wong; Chia Wei Teoh; Atif Awan; Mary Waldron; Tom Cairns; Patrick O'Kelly; Anthony M Dorman; Matthew C Pickering; Peter J Conlon; H Terence Cook
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

5.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

6.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

7.  Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.

Authors:  T S Jokiranta; A Solomon; M K Pangburn; P F Zipfel; S Meri
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

8.  Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique.

Authors:  Nidia C Messias; Patrick D Walker; Christopher P Larsen
Journal:  Mod Pathol       Date:  2015-02-13       Impact factor: 7.842

Review 9.  A protective role for innate immunity in systemic lupus erythematosus.

Authors:  Michael C Carroll
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

Review 10.  The pathogenesis of lupus nephritis.

Authors:  Maciej Lech; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 10.121

View more
  3 in total

1.  Complement your knowledge with a rare cause of pauci-immune glomerulonephritis.

Authors:  H Lomzenski; R Thibodaux; M Guevara
Journal:  Clin Rheumatol       Date:  2018-09-10       Impact factor: 2.980

2.  Complement C3 Produced by Macrophages Promotes Renal Fibrosis via IL-17A Secretion.

Authors:  Yanyan Liu; Kun Wang; Xinjun Liang; Yueqiang Li; Ying Zhang; Chunxiu Zhang; Haotian Wei; Ran Luo; Shuwang Ge; Gang Xu
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

3.  CFHR5 Nephropathy in a Greek-Cypriot Australian Family: Ancestry-Informed Precision Medicine.

Authors:  Monica S Y Ng; Kelly McClymont; Naomi McCallum; Rahul Dua; Katherine Holman; Bruce Bennetts; Gladys Ho; Chirag Patel; Andrew J Mallett
Journal:  Kidney Int Rep       Date:  2018-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.